PDA Block 2 Week 1 Flashcards
(53 cards)
Etanercept
Cytokine interfers with TNF (fused to Fc fragment of IgG--> suicide inhibitor by binding TNF) (acute rxn, fever, sepsis) Autoimmune disease (Rheumatoid arthritis & Crohn's disease)
Infliximab
Cytokine
MAB against TNF Autoimmune disease (Rheumatoid arthritis & Crohn’s disease)
Zileuton
Leukotrienes
5-lipoxygenase inhibitor (inhibits synthesis of leukotrienes)
metabolism: CYP 1A1, 2C9, 3A4
propylactic treatment of mild asthma
Zafirlukast
Leukotrienes competitive leukotriene
Receptor antagonist: inhibit cys-LTs to increase vascular permeability; chemotaxis (LTB4); decrease bronchoconstriction
Metabolism: CYP 2C9
propylactic and chronic treatment of mild askthma
Steroid
glucocorticoids
binds cytoplasmic R–> transcription –> inhibit cytokines, phospholipase A2, COX2, and CAM
chronic inflammatory disease
dinoprostone
PGE2 analog
“1. Gel: promotes cervical ripening, relax cervical muscles (E4R)
2. suppository: pregnancy termination (EP1/3R)- uterine contraction”
GI related, fever, uterine rupture
carboprost
PGF2a analong
IM injection
1. termination of pregnancy at FP R
2. control post-partum hemorrhage
GI related, fever, uterine rupture
misoprostol
PGE1 analog
oral replacement therapy for prevention of ulcers cased by NSAIDS by suppressing gastric acid secretion & increase mucus
diarrhea, contraindicated in pregnancy
alprostadil
PGE1 analog
1. Intracavernous injection
increase cAMP–> relax smooth muscle in erectile dyfunction
2. IV: maintenance of patent ductus arteriosus (relaxation of muscle)
Adverse:
- priapism: prolonged erection
- apnea
epoprostenol
PGEI2 analog
IV: primary pulmonary HTN (cAMP mediated dilation of pulmonary vascular Smooth m.)
Nausea, vomiting, headache, flushing
bimatoprost
PGF2a analog
- Glaucoma (increase outflow of aqueous humor)
- eyelash hypotrichosis (increase length and number of eyelashes)
Adverse
- eye redness, itching
- excess unwanted hair growth, brown pigmentation, redness, itching”
Aldosterone
Steroid "adrenal insufficiency allergic disease inflammatory disease cerebral edema"
“dose is variable
single dose usually does not have harmful effect
used to treat symptoms
abrupt discontinuation may cause adrenal insufficiency” Contraindication: existing infection
Cortisol
Steroid
adrenal insufficiency, inflammation, immunosuppresant
1. dose is variable
2. single dose usually does not have harmful effect
3. used to treat symptoms
4. abrupt discontinuation may cause adrenal insufficiency
Dexamethasone
Steroid
adrenal insufficiency, inflammation, immunosuppresant
1. dose is variable
2. single dose usually does not have harmful effect
3. used to treat symptoms
4. abrupt discontinuation may cause adrenal insufficiency
Prednisolone
Steroid
adrenal insufficiency, inflammation, immunosuppresant
1. dose is variable
2. single dose usually does not have harmful effect
3. used to treat symptoms
4. abrupt discontinuation may cause adrenal
Fludrocortisone
Steroid
adrenal insufficiency, inflammation, immunosuppresant
1. dose is variable
2. single dose usually does not have harmful effect
3. used to treat symptoms
4. abrupt discontinuation may cause adrenal
Metyrapone
Steroid synthesis inhibitor
Blocks 11 Beta hydroxylation –> 11-desoxycortisol does not inhibit ACTH release via neg. feedback–> increase synthesis of 17 hydroxycorticoids (excreted)
Used as a diagnostic test for renal function
Mifepristone
competitive antagonist at progesterone and glucocorticoid R
Terminate pregnancy; treat Cushings
Spironolactone
competitive antagonist at mineralcorticoid R
Diuretic, treat HTN, cardiac hypertrophy and heart failure
Eplerenone
competitive antagonist at mineralcorticoid R
Diuretic, treat HTN, cardiac hypertrophy and heart failure
Drospirenone
- progesterone R agonist: suppress ovulation, hormone replacement therapy with estrogen
- mineralcorticoid R antagonist: diuretic
- androgen R antagonist
Prednisolone
corticosteroid
- cell traffic/accumulation decreased
- interferes with antigen processing, inhibits binding to Fc receptors
used in combination with other drugs to prevent transplant rejection and some autoimmune disease
contraindicated: existing infection
Azathioprine
cytotoxic agent
Metabolized to 6-mercaptopurine–> inhibits De Novo and Salvage pathway
used to inhibit rejection of transplanted organs,
bone marrow depression, BI and hepatic toxicity
Cyclophosphamide
cytotoxic agent
alkalating agent that results in cross-linking DNA to kill replicating and non -replicating cell
Used for treating autoimmune disease
NOT effective for graft rejection
bone marrow depression